gmpua.com
Innovative marketing strategies afterpatent expirycompetition from generics) in favour of aconstraints of the key stakeholder (in thisconsiderable equity and can thus put up acase, the French social security system’ssuccessful defence against generics. This isgoal of reducing the growth in antibioticlittle respect they generally have for theirimplemented in 1996 is no longer valid. intr